Winmill & Co. Inc Biogen Inc. Transaction History

Winmill & Co. Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$242.95 - $284.63 $1.68 Million - $1.96 Million	-6,900 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$258.66 - $342.55 $1.27 Million - $1.68 Million	4,900 Added 245.0%	6,900 $1.85 Million
Q4 2019 Jan 16, 2020	BUY	$220.06 - $304.07 $132,036 - $182,442	600 Added 42.86%	2,000 $593,000
Q3 2019 Oct 15, 2019	BUY	$217.44 - $243.88 $304,416 - $341,432	1,400 New	1,400 $326,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Winmill & Co. Inc, based on Form 13F filings with the SEC.

Stay updated on Winmill & Co. Inc with notifications on news.